Knockdown of CRM1 inhibits the nuclear export of p27Kip1 phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer

Cancer Letters

Volumn 343, Issue 1, 2014, Pages 6-13

  Wang, You ^a,c   Wang, Yingying ^b   Xiang, Jingying ^c   Ji, Fang ^a   Deng, Yan ^b   Tang, Chunhui ^b   Yang, Shuyun ^b   Xi, Qinghua ^b   Liu, Rong ^b   Di, Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANTONG UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chromosomal region maintenance; Epithelial ovarian cancer; P27Kip1; Phosphorylation; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EXPORTIN 1; SERINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; MOUSE; NONHUMAN; OPTICAL DENSITY; OVARY CARCINOMA; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SURVIVAL TIME; TUMOR VOLUME;

EID: 84890859156     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.09.002     Document Type: Article

References (20)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010, 60(2010):277-300.
2. Bao X., Zhao S., Liu T., Liu Y., Yang X. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer. J. Histochem. Cytochem. 2013, 61:206-217.
3. Kuppers D.A., Hwang H.C., Jackson A.L., Linsley P.S., Clurman B.E., Fero M.L. Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma. PLoS ONE 2011, 6:e14758.
4. Viglietto G., Motti M.L., Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 2002, 1:394-400.
5. Sgambato A., Ratto C., Faraglia B., Merico M., Ardito R., Schinzari G., Romano G., Cittadini A.R. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. Mol. Carcinogen. 1999, 26:172-179.
6. Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 2006, 20:47-64.
7. Serres M.P., Zlotek-Zlotkiewicz E., Concha C., Gurian-West M., Daburon V., Roberts J.M., Besson A. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene 2011, 30:2846-2858.
8. Nguyen K.T., Holloway M.P., Altura R.A. The CRM1 nuclear export protein in normal development and disease. Int. J. Biochem. Mol. Biol. 2012, 3:137-151.
9. Hutten S., Kehlenbach R.H. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 2007, 17:193-201.
10. Payton S. Kidney cancer: CRM1 - a novel drug target for renal cell carcinoma?. Nat. Rev. Urol. 2012, 9:672.
11. Wang Y., Cheng C., Ji Y., Zhao Y., Zou L., Shen A. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J. Cancer Res. Clin. Oncol. 2009, 135:951-959.
12. Wang Y., Yang S., Ni Q., He S., Zhao Y., Yuan Q., Li C., Chen H., Zhang L., Zou L., Shen A., Cheng C. Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J. Cell. Biochem. 2012, 113:2729-2737.
13. Shen A., Wang Y., Zhao Y., Zou L., Sun L., Cheng C. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. Neurosurgery 2009, 65:153-159. (discussion 159-160).
14. Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 2002, 277:14355-14358.
15. Kip1 is instigated by Jab1. Nature 1999, 398:160-165.
16. Toyoshima H., Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
17. Turner J.G., Dawson J., Sullivan D.M. Nuclear export of proteins and drug resistance in cancer. Biochem. Pharmacol. 2012, 83:1021-1032.
18. Noske A., Weichert W., Niesporek S., Roske A., Buckendahl A.C., Koch I., Sehouli J., Dietel M., Denkert C. Expression of the nuclear export protein chromosomal region maintenance/export in 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer 2008, 112:1733-1743.
19. Huang W.Y., Yue L., Qiu W.S., Wang L.W., Zhou X.H., Sun Y.J. Prognostic value of CRM1 in pancreas cancer. Clin. Invest. Med. 2009, 32:E315.
20. Yao Y., Dong Y., Lin F., Zhao H., Shen Z., Chen P., Sun Y.J., Tang L.N., Zheng S.E. The expression of CRM1 is associated with prognosis in human osteosarcoma. Oncol. Rep. 2009, 21:229-235.